Stock Price
251.84
Daily Change
-2.90 -1.14%
Monthly
2.64%
Yearly
4.73%
Q1 Forecast
250.35

ResMed reported $145.97M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Ansell USD 1.03B 305.2M Jun/2024
AtriCure USD 49.7M 10K Sep/2025
Baxter International USD 683M 0 Dec/2024
Cochlear AUD 1.18B 19.2M Dec/2024
Cooper Companies USD 198.81M 9K Sep/2025
CSL USD 576M 19M Dec/2024
Dexcom USD 392.2M 391.8M Jun/2025
Edwards Lifesciences USD 587.9M 66.9M Jun/2025
Fisher Paykel Healthcare NZD 587.25M 1.35M Dec/2025
Globus Medical USD 135.05M 134.92M Jun/2025
Haemonetics USD 46.75M 1.41M Sep/2025
Hologic USD 222.57M 350K Sep/2025
Idexx Laboratories USD 80M 63.36M Sep/2025
Insulet USD 70.35M 70.25M Sep/2025
Integra LifeSciences USD 77.92M 77M Jun/2025
Intuitive Surgical USD 354.5M 3.98M Dec/2025
Masimo USD 53.1M 1.2M Sep/2025
Medtronic USD 1.28B 66K Jun/2025
Philips EUR 950.98M 405K Sep/2025
Ramsay Health Care AUD 2.27B 19.6M Dec/2024
ResMed USD 145.97M 25K Dec/2025
Sigma Healthcare AUD 11.5B 9.93B Dec/2025
Sonic Healthcare AUD 4.15B 467K Dec/2024
Steris USD 98.49M 9K Sep/2025
Teleflex USD 44.19M 482K Jun/2025
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025